Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Public ClinicalTrials.gov record NCT04056247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PROPHETIC - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Study identification
- NCT ID
- NCT04056247
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- OncoHost Ltd.
- Industry
- Enrollment
- 10,000 participants
Conditions and interventions
Conditions
Interventions
- Plasma sample collection Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2019
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
- Last update posted
- Oct 14, 2025
2019 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham VAHCS | Birmingham | Alabama | 35233 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Florida Cancer Specialist and Research Institute | Orlando | Florida | 32827 | — |
| Protean Biodiagnosics | Orlando | Florida | 32827 | — |
| Northwest Community Healthcare | Rolling Meadows | Illinois | 60008 | — |
| Helen Nassif Community Cancer Center | Cedar Rapids | Iowa | 52403 | — |
| Rutgers Cancer Institute | New Brunswick | New Jersey | 08903 | — |
| Roswell Park | Buffalo | New York | 14263 | — |
| West Clinic | Germantown | Tennessee | 38138 | — |
| Michael E. Debakey VA Medical Center | Houston | Texas | 77030 | — |
| 151-Christus Health St. Michael | Texarkana | Texas | 75503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04056247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2025 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04056247 live on ClinicalTrials.gov.